Boston Hybrid Employment $154.2K – $195K

Xenon Pharmaceuticals is hiring a Senior Manager, Trial Operations

Responsibilities

  • Develop and implement strategies to enhance trial operations
  • Ensure adherence to regulatory requirements and industry standards
  • Manage and mentor a team of trial operations specialists
  • Collaborate with cross-functional teams to drive trial success
  • Monitor trial progress and address any operational issues
  • Prepare and review trial documentation
  • Conduct risk assessments and implement mitigation strategies
  • Facilitate training sessions for trial staff
  • Manage trial budgets and allocate resources effectively
  • Ensure data integrity and accuracy throughout trial processes
  • Coordinate with external vendors and partners
  • Implement quality control measures
  • Prepare and present trial reports to stakeholders
  • Identify opportunities for process improvement
  • Ensure compliance with Good Clinical Practice (GCP) guidelines
  • Manage trial timelines and milestones
  • Oversee the setup and management of trial sites
  • Conduct regular audits and inspections
  • Ensure patient safety and well-being
  • Collaborate with data management teams
  • Provide input on trial design and protocol development
  • Ensure timely and accurate reporting of trial results

Compensation

Competitive salary and benefits package

Work Arrangement

Hybrid

Team

Reporting to the Director of Clinical Operations, you will lead a team of trial operations specialists.

About Us

  • A biopharmaceutical company focused on developing innovative therapies
  • Committed to improving the lives of patients through scientific excellence
  • Dedicated to advancing the understanding and treatment of neurological disorders
  • Collaborative and inclusive work environment
  • Opportunities for professional growth and development
  • State-of-the-art facilities and resources
  • Strong commitment to ethical research and development practices
  • Focus on innovation and cutting-edge technologies
  • Diverse and talented team of professionals
  • Opportunities for international collaboration and partnerships

What We Offer

  • Competitive salary and benefits package
  • Opportunities for professional development and growth
  • Collaborative and inclusive work environment
  • State-of-the-art facilities and resources
  • Flexible work arrangements
  • Supportive and dynamic team culture
  • Opportunities for international collaboration and partnerships
  • Commitment to ethical research and development practices
  • Focus on innovation and cutting-edge technologies
  • Diverse and talented team of professionals

Our Culture

  • Collaborative and inclusive work environment
  • Commitment to ethical research and development practices
  • Focus on innovation and cutting-edge technologies
  • Diverse and talented team of professionals
  • Opportunities for professional growth and development
  • Supportive and dynamic team culture
  • State-of-the-art facilities and resources
  • Opportunities for international collaboration and partnerships
  • Dedicated to advancing the understanding and treatment of neurological disorders
  • Strong commitment to patient safety and well-being

Not specified

Freelancing without stability?

Get steady projects, keep your freedom

Iglu connects you with international clients and handles contracts, payments, and admin. You get consistent work and flexibility — no more chasing invoices or worrying about gaps.

Consistent client projects
Contract & payment management
Flexible work schedule
Revenue-sharing compensation
See open positions
Work from anywhere
About company
Xenon Pharmaceuticals
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team. We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting, and continue to advance an early-stage pipeline of novel therapeutic candidates. In 2025, we initiated Phase 1 trials for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7). Nav1.7 and Kv7 are important pain targets, and data from these Phase 1 studies are expected in 2026 to support Phase 2 proof-of-concept studies in acute pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
All jobs at Xenon Pharmaceuticals Visit website
Job Details
Department Clinical Development, Trial Operations
Category other
Posted 10 days ago